Simplify your online presence. Elevate your brand.

Domo Health Pharma Giant Roche Supports Domo Health Clinical Study

Domo Health Pharma Giant Roche Supports Domo Health Clinical Study
Domo Health Pharma Giant Roche Supports Domo Health Clinical Study

Domo Health Pharma Giant Roche Supports Domo Health Clinical Study In collaboration with roche pharma suisse sa, the patient association sma schweiz, chuv and inselspital, domo health has launched a clinical study to develop digital biomarkers to detect hypoventilation and warning signs of respiratory infections. By combining a home alert system, clinical expertise and real time health data, the domo health platform is able to detect the first signs of illness and caregivers, the emergency center and doctors are directly alerted. therefore, care is provided as quickly as possible, wherever the patient is.

Domo Health Pharma Giant Roche Supports Domo Health Clinical Study
Domo Health Pharma Giant Roche Supports Domo Health Clinical Study

Domo Health Pharma Giant Roche Supports Domo Health Clinical Study Domo health, a leader in digital health, announced today from the biotechx congress in basel, the launch of its clinical study in collaboration with roche pharma suisse sa, that aims to. Domo health, a leader in digital health, announced today from the biotechx congress in basel, the launch of its clinical study in collaboration with roche pharma suisse sa, that aims to develop a digital health solution detecting hypoventilation and warning signs of respiratory infections. Domo health announced wednesday that it has launched a clinical study of a digital health solution it is co developing with roche to detect hypoventilation and other warning signs of respiratory infections. Domo health announced today from the biotechx congress in basel, the launch of its clinical study in collaboration with roche pharma, that aims to develop a digital health solution.

Domo Health Pharma Giant Roche Supports Domo Health Clinical Study
Domo Health Pharma Giant Roche Supports Domo Health Clinical Study

Domo Health Pharma Giant Roche Supports Domo Health Clinical Study Domo health announced wednesday that it has launched a clinical study of a digital health solution it is co developing with roche to detect hypoventilation and other warning signs of respiratory infections. Domo health announced today from the biotechx congress in basel, the launch of its clinical study in collaboration with roche pharma, that aims to develop a digital health solution. Our intuitive digital health platform leverages ai and real world data from homecare management, connected medical devices, and patient insights to transform remote patient monitoring and empower healthcare professionals and patients. Domo health focuses in particular on chronic diseases such as cardiovascular disease, parkinson's, alzheimer's, cancer, multiple sclerosis and spinal muscular atrophy. the latter is currently the subject of a clinical study in collaboration with roche and the chuv. As part of the collaboration between roche and domo health, roche is supporting a project during which domo will adapt its evolutive platform to the needs of sma patients.

Cision Mediastudio View Media
Cision Mediastudio View Media

Cision Mediastudio View Media Our intuitive digital health platform leverages ai and real world data from homecare management, connected medical devices, and patient insights to transform remote patient monitoring and empower healthcare professionals and patients. Domo health focuses in particular on chronic diseases such as cardiovascular disease, parkinson's, alzheimer's, cancer, multiple sclerosis and spinal muscular atrophy. the latter is currently the subject of a clinical study in collaboration with roche and the chuv. As part of the collaboration between roche and domo health, roche is supporting a project during which domo will adapt its evolutive platform to the needs of sma patients.

Comments are closed.